Beta Bionics, Inc. BBNX
16.95 USD +1.85 (+12.25%)
At closeNov 4, 2026, 4:00 PM EST
16.95 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
15.18 Day range 16.95
8.80 52-week range 32.71
- YTD
- -44.37%
- 1 year
- -39.05%
Financial health
Altman Z-Score
9.35 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -16.8×
FY 2022 5y median -17.6× FY 2025
P/S 12.3×
FY 2022 5y median 50.0× FY 2025
P/B 4.3×
FY 2022 5y median 8.8× FY 2025
P/FCF -22.0×
FY 2022 5y median -20.8× FY 2025
EV/EBITDA -17.2×
FY 2022 5y median -18.0× FY 2025
EV/Sales 12.1×
FY 2022 5y median 48.9× FY 2025
FCF Yield -4.6%
FY 2022 5y median -4.8% FY 2025
Profitability
Gross Margin 55.4%
FY 2022 5y median 55.3% FY 2025
Operating Margin -71.5%
FY 2022 5y median -185.2% FY 2025
Net Margin -73.0%
FY 2022 5y median -225.9% FY 2025
ROE -25.5%
FY 2022 5y median -48.7% FY 2025
ROIC -23.9%
FY 2022 5y median -35.2% FY 2025
ROA -22.3%
FY 2022 5y median -38.3% FY 2025
Growth (YoY)
Revenue 53.9%
FY 2022 FY 2025
Operating Income -58.4%
FY 2022 FY 2025
EPS (diluted) -41.4%
FY 2022 FY 2025
Free Cash Flow -8.8%
FY 2022 FY 2025
Financial Health
Current Ratio 8.7×
FY 2022 5y median 7.5× FY 2025
Quick Ratio 8.0×
FY 2022 5y median 6.8× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2022 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31